It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Understand the Impact Of High Utilization On Credit Score 2024, including common causes and remedies. Practical steps to lower utilization and protect your score.
25,781 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Is Micron stock under a lofty price point worth buying? This article breaks down the key factors, including memory ma...
Two tech giants with divergent business lines are converging as tech dopplegangers, challenging investors to navigate...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
Meta and Microsoft posted strong results, yet insider selling patterns diverged sharply. Meta's executives have been ...
AI stocks surged on hype, not just earnings. Yet after robust results from taiwan semiconductor and ASML, the market ...
When a MongoDB director sells a sizable block of shares, investors pause to weigh the meaning. This article breaks do...
Accelerant Holdings has fallen sharply since its IPO, but a major fund just took a sizable stake. This article explai...
A sharp 20% drop has many investors asking if PayPal stock is a bargain or a value trap. This guide breaks down the b...
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...
Analyzing octave specialty (osg) earnings calls goes beyond quarterly numbers. This guide breaks down the key metrics...